Tirzepatide is a newer medication that works on two hormone pathways—GLP-1 and GIP—to help regulate appetite, fullness, and blood sugar. By targeting both pathways, tirzepatide may provide a stronger effect on appetite and weight management for some patients compared with GLP-1-only medications. Like semaglutide, it is given once weekly and is prescribed and adjusted based on each patient’s individual needs, response, and treatment goals.
Tirzepatide is a newer medication that works on two hormone pathways—GLP-1 and GIP—to help regulate appetite, fullness, and blood sugar. By targeting both pathways, tirzepatide may provide a stronger effect on appetite and weight management for some patients compared with GLP-1-only medications. Like semaglutide, it is given once weekly and is prescribed and adjusted based on each patient’s individual needs, response, and treatment goals.